Curtin University Homepage
  • Library
  • Help
    • Admin

    espace - Curtin’s institutional repository

    JavaScript is disabled for your browser. Some features of this site may not work without it.
    View Item 
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item

    Alzheimer's Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies-Gains from AIBL and DIAN Cohort Studies

    Access Status
    Fulltext not available
    Authors
    Martins, R.
    Villemagne, V.
    Sohrabi, H.
    Chatterjee, P.
    Shah, T.
    Verdile, Giuseppe
    Fraser, P.
    Taddei, K.
    Gupta, V.
    Rainey-Smith, S.
    Hone, E.
    Pedrini, S.
    Lim, W.
    Martins, I.
    Frost, S.
    Gupta, S.
    O'Bryant, S.
    Rembach, A.
    Ames, D.
    Ellis, K.
    Fuller, S.
    Brown, B.
    Gardener, S.
    Fernando, B.
    Bharadwaj, Prashant
    Burnham, S.
    Laws, S.
    Barron, A.
    Goozee, K.
    Wahjoepramono, E.
    Asih, P.
    Doecke, J.
    Salvado, O.
    Bush, A.
    Rowe, C.
    Gandy, S.
    Masters, C.
    Date
    2018
    Type
    Journal Article
    
    Metadata
    Show full item record
    Citation
    Martins, R. and Villemagne, V. and Sohrabi, H. and Chatterjee, P. and Shah, T. and Verdile, G. and Fraser, P. et al. 2018. Alzheimer's Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies-Gains from AIBL and DIAN Cohort Studies. Journal of Alzheimer's Disease. 62 (3): pp. 965-992.
    Source Title
    Journal of Alzheimer's Disease
    DOI
    10.3233/JAD-171145
    ISSN
    1387-2877
    School
    School of Pharmacy and Biomedical Sciences
    URI
    http://hdl.handle.net/20.500.11937/67607
    Collection
    • Curtin Research Publications
    Abstract

    © 2018-IOS Press and the authors. All rights reserved. Worldwide there are over 46 million people living with dementia, and this number is expected to double every 20 years reaching about 131 million by 2050. The cost to the community and government health systems, as well as the stress on families and carers is incalculable. Over three decades of research into this disease have been undertaken by several research groups in Australia, including work by our original research group in Western Australia which was involved in the discovery and sequencing of the amyloid-β peptide (also known as Aβ or A4 peptide) extracted from cerebral amyloid plaques. This review discusses the journey from the discovery of the Aβ peptide in Alzheimer's disease (AD) brain to the establishment of pre-clinical AD using PET amyloid tracers, a method now serving as the gold standard for developing peripheral diagnostic approaches in the blood and the eye. The latter developments for early diagnosis have been largely achieved through the establishment of the Australian Imaging Biomarker and Lifestyle research group that has followed 1,100 Australians for 11 years. AIBL has also been instrumental in providing insight into the role of the major genetic risk factor apolipoprotein E ϵ4, as well as better understanding the role of lifestyle factors particularly diet, physical activity and sleep to cognitive decline and the accumulation of cerebral Aβ.

    Related items

    Showing items related by title, author, creator and subject.

    • Disruption of blood-brain barrier function by chronic intake of saturated fat and cholesterol : implications for Alzheimer’s disease risk
      Takechi, Ryusuke (2010)
      It has been reported that lifestyle including diet is associated with Alzheimer’s disease (AD) risk and progression. Population studies indicate that the chronic consumption of diets enriched in saturated fats (SFA) and ...
    • Validation and characterisation of a novel peptide that binds monomeric and aggregated beta-amyloid and inhibits the formation of neurotoxic oligomers
      Barr, R.; Verdile, Giuseppe; Wijaya, L.; Morici, M.; Taddei, K.; Gupta, V.; Pedrini, S.; Jin, L.; Nicollazzo, J.; Knock, E.; Fraser, P.; Martins, R. (2015)
      Although the formation of β-amyloid (Aβ) deposits in the brain is a hallmark of Alzheimer disease (AD), the soluble oligomers rather than the mature amyloid fibrils most likely contribute to Aβ toxicity and neurodegeneration. ...
    • Dysregulation of neuronal iron homeostasis as an alternative unifying effect of mutations causing familial Alzheimer's disease
      Lumsden, A.; Rogers, J.; Majd, S.; Newman, M.; Sutherland, G.; Verdile, Giuseppe; Lardelli, M. (2018)
      The overwhelming majority of dominant mutations causing early onset familial Alzheimer's disease (EOfAD) occur in only three genes, PSEN1, PSEN2, and APP. An effect-in-common of these mutations is alteration of production ...
    Advanced search

    Browse

    Communities & CollectionsIssue DateAuthorTitleSubjectDocument TypeThis CollectionIssue DateAuthorTitleSubjectDocument Type

    My Account

    Admin

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Follow Curtin

    • 
    • 
    • 
    • 
    • 

    CRICOS Provider Code: 00301JABN: 99 143 842 569TEQSA: PRV12158

    Copyright | Disclaimer | Privacy statement | Accessibility

    Curtin would like to pay respect to the Aboriginal and Torres Strait Islander members of our community by acknowledging the traditional owners of the land on which the Perth campus is located, the Whadjuk people of the Nyungar Nation; and on our Kalgoorlie campus, the Wongutha people of the North-Eastern Goldfields.